Clinical trials · New York
Glaucoma clinical trials in New York
We’re tracking 9 recruiting glaucoma studies with a site in New York — including Phase 1 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies in New York
- NCT07220876Recruiting
VisiPlate implant for hard-to-control open-angle glaucoma
This trial tests a new device called VisiPlate that is placed in the eye to help lower pressure for people with hard-to-control open-angle glaucoma. It may be an option if standard treatments haven't worked well enough.
New York, New YorkAges 45 years+ - NCT06822738RecruitingPhase 3
Study of XEN63 gel stent for glaucoma patients
This trial tests a new gel stent (XEN63) to lower eye pressure in adults with glaucoma. It compares two ways of putting the stent in the eye, and may help people who have not had success with other treatments.
New York, New YorkAges 45 years+ - NCT07520175Enrolling by invitation
Bio-Reinforced Canaloplasty for Open-Angle Glaucoma
This study tests a newer surgical procedure called bio-reinforced canaloplasty, which helps fluid drain better from the eye to lower eye pressure in people with open-angle glaucoma. Researchers will follow patients to see how well this procedure works and how safe it is.
Buffalo, New YorkAges Any age - NCT07290244RecruitingPhase 1
Testing ER-100 safety for glaucoma or NAION patients
This trial tests whether a new drug, ER-100, is safe for people with glaucoma or a sudden optic nerve injury called NAION. It aims to see if the drug can be given without serious side effects.
New York, New YorkAges 40–85 - NCT05924477Recruiting
Compare glaucoma shunt options to prevent cell loss
This study compares a glaucoma drainage device approach to see which one better prevents loss of corneal cells after surgery. You may benefit by receiving close monitoring around the time of glaucoma surgery and helping doctors improve surgical choices.
Buffalo, New YorkAges 18 years+ - NCT07425496Recruiting
Eye fluid dynamics study during surgery
This trial measures eye fluid flow during cataract or glaucoma surgery. It aims to help doctors predict and improve surgery results.
New York, New YorkAges 18 years+ - NCT03933631RecruitingPhase 3
Pilocarpine eye drops after glaucoma drainage surgery
This trial tests whether pilocarpine eye drops work better after a specific glaucoma surgery called Kahook goniotomy done at the same time as cataract surgery. It may help lower eye pressure and support better glaucoma control after surgery.
The Bronx, New YorkAges 30–100 - NCT05523622Recruiting
Testing a new eye pressure measuring device
This study compares a new device (TonoVera) against other common tools used to measure eye pressure. It may help show whether the new device gives accurate readings and is practical for routine eye exams.
Buffalo, New YorkAges Any age - NCT04967989RecruitingPhase 3
Laser eye treatment timing for certain glaucoma or eye pressure
This Phase 3 study tests how best to use a laser treatment (SLT) for people with high eye pressure or mild-to-moderate primary open-angle glaucoma. It aims to find the best way to lower eye pressure and protect vision while comparing treatment approaches.
The Bronx, New YorkAges 18 years+
Glaucoma trials by city in New York
Where these studies are running in New York
Institutions with a site for the recruiting glaucoma studies listed above.
- Ross Eye Institute · 2 studies
- Columbia University Irving Medical Center/Edward S. Harkness Eye Institute
- Montefiore Medical Center
- Montefiore Wakefield Campus
- New York Eye and Ear Infirmary of Mount Sinai
- New York Eye Surgery Associates
- NYC Glaucoma /ID# 283103
- NYC Retina
What taking part in a glaucoma study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Glaucoma trials in other states
Common questions
- Are there glaucoma clinical trials in New York?
- Yes. We're currently tracking 9 recruiting glaucoma studies with a site in New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a glaucoma study in New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site in New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a glaucoma trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New glaucoma studies open in New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.